Scott Akamine's Insider Trades & SAST Disclosures
Scott Akamine's most recent trade in Cerevel Therapeutics Holdings Inc was a trade of 59,171 Restricted Stock Units done . Disclosure was reported to the exchange on Jan. 19, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Scott Akamine.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cerevel Therapeutics Holdi... | Akamine Scott | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2024 | 59,171 | 59,171 | - | - | Restricted Stock Units | |
| Cerevel Therapeutics Holdi... | Scott Akamine | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2023 | 13,796 | 14,309 | - | - | Common Stock | |
| Cerevel Therapeutics Holdi... | Akamine Scott | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2023 | 13,796 | 0 | - | - | Restricted Stock Units | |
| Cerevel Therapeutics Holdi... | Scott Akamine | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 41.42 per share. | 19 Dec 2023 | 7,072 | 7,237 | - | 41.4 | 292,945 | Common Stock |
| Cerevel Therapeutics Holdi... | Scott Akamine | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.17 per share. | 05 Dec 2023 | 10,000 | 10,513 | - | 13.2 | 131,700 | Common Stock |
| Cerevel Therapeutics Holdi... | Akamine Scott | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2023 | 10,000 | 254,262 | - | - | Stock Option (Right to Buy) | |
| Cerevel Therapeutics Holdi... | Akamine Scott | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 41.37 per share. | 05 Dec 2023 | 10,000 | 513 | - | 41.4 | 413,700 | Common Stock |
| Cerevel Therapeutics Holdi... | Akamine Scott | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2023 | 7,500 | 264,262 | - | - | Stock Option (Right to Buy) | |
| Cerevel Therapeutics Holdi... | Akamine Scott | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 05 Dec 2023 | 7,500 | 513 | - | 35 | 262,500 | Common Stock |
| Cerevel Therapeutics Holdi... | Scott Akamine | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.17 per share. | 05 Dec 2023 | 7,500 | 8,013 | - | 13.2 | 98,775 | Common Stock |
| Cerevel Therapeutics Holdi... | Scott Akamine | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2023 | 54,292 | 54,292 | - | - | Stock Option (Right to Buy) | |
| Cerevel Therapeutics Holdi... | Scott Akamine | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2023 | 13,796 | 13,796 | - | - | Restricted Stock Units | |
| Cerevel Therapeutics Holdi... | Scott Akamine | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 08 Aug 2022 | 10,000 | 0 | - | 40.0 | 400,001 | Common Stock |
| Cerevel Therapeutics Holdi... | Scott Akamine | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.17 per share. | 08 Aug 2022 | 10,000 | 10,000 | - | 13.2 | 131,700 | Common Stock |
| Cerevel Therapeutics Holdi... | Scott Akamine | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2022 | 10,000 | 271,762 | - | - | Stock Option (Right to Buy) | |
| Cerevel Therapeutics Holdi... | Scott Akamine | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 281,762 | 281,762 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges